Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | FSCN1 | Q16658 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3784021 | 0.81 | ALDH1A1 (0.46) | ALDH1A1TSHRALOX15HSD17B10GAA | |
| SCHEMBL2056277 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15HSD17B10KMT2A | |
| SCHEMBL18346846 | 0.80 | CHEK1 (0.44) | ALDH1A1TSHRALOX15HSD17B10GAA | |
| SCHEMBL11766128 | 0.78 | SLC2A1 (0.49) | ALDH1A1TSHRALOX15HSD17B10GAA | |
| SCHEMBL19785366 | 0.78 | ALDH1A1 (0.48) | ALDH1A1TSHRALOX15HSD17B10GAA | |
| SCHEMBL2616324 | 0.78 | GAA (0.59) | TSHRHSD17B10GAAKMT2AFSCN1 | |
| SCHEMBL21173494 | 0.77 | ALDH1A1 (0.53) | ALDH1A1TSHRALOX15HSD17B10GAA | |
| SCHEMBL31366224 | 0.76 | CYP3A4 (0.48) | ALDH1A1TSHRALOX15HSD17B10GAA | |
| SCHEMBL12483803 | 0.76 | KMT2A (0.42) | ALDH1A1TSHRGAAKMT2AFSCN1 | |
| SCHEMBL10153909 | 0.76 | CYP3A4 (0.48) | ALDH1A1TSHRALOX15HSD17B10GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| EP-0675404-B1 | Image forming process | KONISHIROKU PHOTO IND (JP) | 2001-09-26 | — | — | EP | disclosed |
| EP-0675404-A1 | Image forming process | KONICA CORPORATION (JP) | 1995-10-04 | — | — | EP | disclosed |
| US-4840879-A | COLORED LATENT IMAGE IS REACTION PRODUCT OF COUPLER AND AROMATIC PRIMARY AMINO COLOR DEVELOPER | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1989-06-20 | — | — | US | disclosed |
| US-4330616-A | STABILIZING AN AQUEOUS AMINE-CONTAINING DEVELOPING SOLUTION WITH A DIPHOSPHONIC ACID, METAL SALT, IMINODICARBONIC OR POLYPHO0PHORIC ACID | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1982-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | ALDH1A1 4339/4885TSHR 1688/4885ALOX15 1941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.